Skip to content
Homepage
Clinic directory

Clinics in Omaha, Nebraska

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Omaha, NE

Peptide Therapy clinics in Omaha

Omaha has a stable Midwestern healthcare hub anchored by Nebraska Medicine and full NP practice authority, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across West Omaha, Dundee, and Midtown range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Nebraska Medicine, CHI Health, and Methodist network. The scene here skews toward NP-run and DO-run clinics offering peptides alongside hormone optimization. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Omaha clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.

33 Clinics, showing page 3 of 3

Melissa Loseke, DO - Wellness and Longevity

Omaha, NE

Melissa Loseke, DO – Wellness and Longevity, in Omaha, offers integrative medicine and regenerative therapies focused on longevity and midlife optimization. The practice specializes in bioidentical h…

  • PRP Therapy
  • Ozone Therapy
  • Laser Therapy (LLLT)
  • Arthritis Treatment
  • Peptide Therapy

Dr. Ryan Goss

Omaha, NE

Dr. Ryan Goss, a chiropractic clinic in Omaha, combines spinal manipulation and decompression with peptide therapy and red-light therapy for patients pursuing longevity and functional restoration. Th…

  • Shockwave Therapy
  • Peptide Therapy
  • Red Light Therapy
MD on staff

Omaha Health Therapy Center

Omaha, NE

Omaha Health Therapy Center, led by Sarah A. Kracht, APRN, BC-FNP, offers a comprehensive range of regenerative and supportive-medicine treatments in Omaha, Nebraska. The practice specializes in ozon…

  • NAD IV Therapy
  • Vitamin IV Therapy
  • PRP Therapy
  • Colon Hydrotherapy
  • Ozone Therapy

Regulatory context

A note on Nebraska's peptide therapy rules.

Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting 503A pharmacy sourcing. Section 503A covers traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.

  • Nebraska Revised Statutes Chapter 38 Article 27 (Pharmacy Practice)
    Governs pharmacy licensure and compounding under the Nebraska Board of Pharmacy.
  • Nebraska Revised Statutes Chapter 38 Article 20 (Medicine and Surgery Practice)
    Regulates physician prescribing and delegation.
  • 172 NAC Chapter 128 (Pharmacy Practice)
    Implements compounding standards consistent with USP 795 and 797.

The Nebraska Board of Pharmacy, operating under the Department of Health and Human Services, inspects compounding pharmacies for USP compliance. Non-resident pharmacies shipping peptides into Nebraska must hold a current non-resident pharmacy license. Disciplinary actions are published through the DHHS licensure system.

Peptide Therapy in Omaha, answered.

Omaha clinics most commonly offer sermorelin and sermorelin plus ipamorelin blends for growth hormone support, both of which are FDA-approved for adult GH deficiency. Healing peptides like BPC-157 and thymosin beta-4 (TB-500) are sometimes offered, but neither is FDA-approved and both landed on the FDA's Category 2 bulk list in 2023, which restricts compounding pharmacy sourcing. CJC-1295 and tesamorelin (Egrifta) appear in some protocols; tesamorelin is FDA-approved for HIV-associated lipodystrophy only. Melanotan II, epithalon, and selank are not FDA-approved.

$250 to $425 per month for sermorelin or sermorelin plus ipamorelin blends. $350 to $600 per month for BPC-157 plus TB-500 protocols when available. $325 to $575 per month for peptide plus hormone optimization bundles. Expect $250 to $550 upfront for initial labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) and the intake consult. Most clinics expect a 3 to 6 month commitment with monthly or quarterly follow-ups, and injection supplies and shipping from the compounding pharmacy are usually bundled into the monthly price.

Sermorelin and tesamorelin are FDA-approved for specific indications, so those are the only peptides a Nebraska clinic can prescribe as standard practice with full FDA backing. BPC-157, CJC-1295, ipamorelin, thymosin beta-4 (TB-500), epithalon, melanotan, and most other research peptides are not FDA-approved. The FDA's 2023-2024 Category 2 bulk substances list decision meant 503A compounding pharmacies lost legal access to many of those ingredients, so availability fluctuates. Any Omaha clinic that still offers a long menu of non-approved peptides should disclose exactly where those ingredients come from.

Nebraska grants nurse practitioners full practice authority, so NPs can evaluate, prescribe, and manage peptide protocols independently. Compounding pharmacy partnership remains required for custom peptide prescriptions, and most clinics work with a 503A pharmacy licensed in the state. The Nebraska Department of Health and Human Services licenses prescribers and the Nebraska Board of Pharmacy regulates compounding. Peptides are typically administered by subcutaneous injection at home after a training session at the clinic, though some Omaha offices offer in-clinic injections. Be wary of non-clinical operators selling peptides labeled as research chemicals, which is a federal red flag regardless of state law.

Verify the prescribing physician's active license through the Nebraska medical board and confirm their NPI number through the NPPES registry. Ask which 503A compounding pharmacy supplies the peptides and whether that pharmacy is licensed in Nebraska. Request baseline labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) before starting any growth hormone peptide, and confirm a monitoring schedule. Reputable Omaha clinics in West Omaha will clearly distinguish FDA-approved peptides from off-label compounds and avoid marketing research chemicals to the public.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology